NK cell immunoglobulin receptors CD226 and CD96 that interact with the nectin-like ligand CD112 and the polio-virus receptor CD155 on target cells are emerging as important mediators of NK cell anti-cancer functions [21–23]. This evidence concerns the gene PVR and cancer.